Friday, October 31, 2014
Inquirer Daily News

Archive: February, 2012

Why 'Moneyball' is no panacea for pharma

Wednesday, February 8, 2012, 12:23 PM
One of the movies that will receive attention and possibly some awards on Oscar night is Moneyball, based on the true story of baseball's Oakland Athletics. Now it appears that some people in pharma are trying to copy what Oakland and other baseball teams did a decade ago. The likely result is that... Read more

“Denursifying” of schools puts children at added risk of medication errors

Tuesday, February 7, 2012, 12:21 PM
According to the Philadelphia Federation of Teachers, the layoff of 47 school nurses in December has led to medications being handed out to school children by “principals, gym teachers, counselors, community liaisons, secretaries, and even aides who normally monitor the playground.” By... Read more

For health reform, constitutionality is not a matter of all or nothing

Friday, February 3, 2012, 2:49 PM
The Supreme Court will decide in a few months whether health reform is constitutional. If the decision is no, where does that leave “Obamacare”? The answer is that most of it could end up remaining intact. Opponents claim that Congress lacked authority to impose the law’s mandate... Read more

The meaning of hospitals buying cardiology practices

Wednesday, February 1, 2012, 1:57 PM
Last week The Inquirer's Stacey Burling wrote about the large number of cardiologists who are selling their practices to hospital networks. Here is what that trend means. 1. Burling correctly mentioned that cardiologists are selling their practices because flat to declining reimbursements are stagnating... Read more
About this blog

Check Up covers major health events in our region and offers everything from personal health advice to an expert look at health reform. Read about some of our bloggers here.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Also on Philly.com:
Stay Connected